Αποτελέσματα αναζήτησης - Jacqueline Nicholas

  • Εμφανίζονται 1 - 8 Αποτελέσματα από 8
Περιορισμός αποτελεσμάτων
  1. 1
    Relapse rates in patients with multiple sclerosis treated with fingolimod: Subgroup analyses of pooled data from three phase 3 trials

    Relapse rates in patients with multiple sclerosis treated with fingolimod: Subgroup analyses of pooled data from three phase 3 trials από Tobias Derfuß, Daniel Ontaneda, Jacqueline Nicholas, Xiangyi Meng, Kathleen Hawker

    Έκδοση 2016
    Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου
    Artigo
    Προσθήκη στα αγαπημένα
    Αποθηκεύτηκε σε:
  2. 2
    Real-world adherence to, and persistence with, once- and twice-daily oral disease-modifying drugs in patients with multiple sclerosis: a systematic review and meta-analysis

    Real-world adherence to, and persistence with, once- and twice-daily oral disease-modifying drugs in patients with multiple sclerosis: a systematic review and meta-analysis από Jacqueline Nicholas, Natalie C. Edwards, Roger Edwards, Anna Dellarole, Megan Grosso, Amy Phillips

    Έκδοση 2020
    Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου
    Revisão
    Προσθήκη στα αγαπημένα
    Αποθηκεύτηκε σε:
  3. 3
    Comparative Effectiveness Research of Disease-Modifying Therapies for the Management of Multiple Sclerosis: Analysis of a Large Health Insurance Claims Database

    Comparative Effectiveness Research of Disease-Modifying Therapies for the Management of Multiple Sclerosis: Analysis of a Large Health Insurance Claims Database από Aaron Boster, Jacqueline Nicholas, Ning Wu, Wei‐Shi Yeh, Monica Fay, Michael Edwards, Ming‐Yi Huang, Andrew Lee

    Έκδοση 2017
    Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου
    Artigo
    Προσθήκη στα αγαπημένα
    Αποθηκεύτηκε σε:
  4. 4
    Comparative effectiveness of dimethyl fumarate versus fingolimod and teriflunomide among MS patients switching from first-generation platform therapies in the US

    Comparative effectiveness of dimethyl fumarate versus fingolimod and teriflunomide among MS patients switching from first-generation platform therapies in the US από Daniel Ontaneda, Jacqueline Nicholas, Matthew Carraro, Jia Zhou, Qiang Hou, Jaanai Babb, Katherine Riester, Jason P. Mendoza, Terrie Livingston, Mehul Jhaveri

    Έκδοση 2018
    Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου
    Artigo
    Προσθήκη στα αγαπημένα
    Αποθηκεύτηκε σε:
  5. 5
    Safety experience with continued exposure to ofatumumab in patients with relapsing forms of multiple sclerosis for up to 3.5 years

    Safety experience with continued exposure to ofatumumab in patients with relapsing forms of multiple sclerosis for up to 3.5 years από Stephen L. Hauser, Anne H. Cross, Kevin Winthrop, Heinz Wiendl, Jacqueline Nicholas, Sven G. Meuth, Paul S. Giacomini, Francesco Saccà, Linda Mancione, Ronald Zielman, Morten Bagger, Ayan Das Gupta, Dieter A. Häring, Valentine Jehl, Bernd C. Kieseier, Ratnakar Pingili, Dee Stoneman, Wendy Su, Roman Willi, Ludwig Kappos

    Έκδοση 2022
    Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου
    Artigo
    Προσθήκη στα αγαπημένα
    Αποθηκεύτηκε σε:
  6. 6
    Associations of<scp>sNfL</scp>with clinico‐radiological measures in a large<scp>MS</scp>population

    Associations of<scp>sNfL</scp>with clinico‐radiological measures in a large<scp>MS</scp>population από Elias S. Sotirchos, Kathryn C. Fitzgerald, Carol M. Singh, Matthew D. Smith, Maria Reyes‐Mantilla, Carrie M. Hersh, Megan Hyland, Ryan Canissario, Sarah B. Simmons, Georgina Arrambide, Xavier Montalbán, Manuel Comabella, Robert T. Naismith, Min Qiao, Lauren Krupp, Jacqueline Nicholas, Katja Akgün, Tjalf Ziemssen, Richard A. Rudick, Elizabeth Fisher, Robert Bermel, Ellen M. Mowry, Peter A. Calabresi

    Έκδοση 2022
    Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου
    Artigo
    Προσθήκη στα αγαπημένα
    Αποθηκεύτηκε σε:
  7. 7
    Harnessing Real-World Data to Inform Decision-Making: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS)

    Harnessing Real-World Data to Inform Decision-Making: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS) από Ellen M. Mowry, Robert Bermel, James R. Williams, Tammie L.S. Benzinger, Carl de Moor, Elizabeth Fisher, Carrie M. Hersh, Megan Hyland, Izlem Izbudak, Stephen E. Jones, Bernd C. Kieseier, Hagen H. Kitzler, Lauren Krupp, Yvonne W. Lui, Xavier Montalbán, Robert T. Naismith, Jacqueline Nicholas, Fabio Pellegrini, Àlex Rovira, Maximilian Schulze, Björn Tackenberg, Mar Tintoré, Madalina E. Tivarus, Tjalf Ziemssen, Richard A. Rudick

    Έκδοση 2020
    Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου
    Artigo
    Προσθήκη στα αγαπημένα
    Αποθηκεύτηκε σε:
  8. 8
    Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study

    Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study από Amit Bar‐Or, Heinz Wiendl, Xavier Montalbán, Enríque Alvarez, M. V. Davydovskaya, Silvia Delgado, Evgeniy Evdoshenko, Nataša Giedraitienė, Katrin Gross‐Paju, Sulev Haldre, Craig Herrman, Guillermo Izquierdo, Guntis Karelis, Fritz Leutmezer, Miroslav Mareš, José Meca-Lallana, Dalia Mickevičienė, Jacqueline Nicholas, Derrick Robertson, Д В Сазонов, Kenneth Sharlin, Bharathy Sundaram, N. А. Totolyan, Marta Vachová, Martin Vališ, Morten Bagger, Dieter A. Häring, Inga Ludwig, Roman Willi, Martin Zalesak, Wendy Su, Martin Merschhemke, Edward Fox

    Έκδοση 2021
    Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου
    Artigo
    Προσθήκη στα αγαπημένα
    Αποθηκεύτηκε σε:

Εργαλεία αναζήτησης: